Human parotid salivas were collected from patients with secondary Sjogren's
syndrome and controls without disease or with drug-induced xerostomia. Par
otid glycoproteins were separated by gradient sodium dodecyl sulphate gel e
lectrophoresis (SDS-PAGE), electroblotted onto nitrocellulose membrane and
probed with biotinylated lectins of characterised sugar specificities. The
binding patterns of lectins from Maclura pomifera (MPA) and Arachis hypogae
a (PNA) indicated that many parotid glycoproteins have sialylated O-linked
glycans and that sialylation is not affected by disease. Binding by lectins
from Ricinus communis (RCA-1), Limax flavus (LFA), Lotus tetragonolobus (L
TA) and Ulex europaeus (UEA-1) appeared unaltered in secondary Sjogren's sy
ndrome, suggesting no obvious change in N-glycosylation of parotid glycopro
teins. Variations in binding patterns of most lectins was attributable to s
ubject-to-subject variations in recognised polymorphic proteins. Dolichos b
iflorus agglutinin (DBA) consistently showed increased binding to a 75 kDa
(M-r) protein in salivas from patients with secondary Sjogren's syndrome. T
he binding protein was identified as lactoferrin but found not to contain N
-acetylgalactosamine, the sugar to which DBA binds. Binding of DBA to lacto
ferrin was dependent upon its saturation with iron, modified SDS-PAGE under
nonreducing conditions resolved iron-free and iron-saturated lactoferrins
and demonstrated increased levels of the iron-saturated form in secondary S
jogren's syndrome. Lectin binding studies of purified lactoferrins from sal
iva, milk, and polymorphonuclear neutrophils suggested that raised levels o
f lactoferrin in saliva originate from salivary cells and not from inflamma
tory cells. These results suggest that DBA binding provides greater specifi
city as an indicator of salivary gland disease than measurement of lactofer
rin levels alone.